Literature DB >> 34334951

The coSIR model predicts effective strategies to limit the spread of SARS-CoV-2 variants with low severity and high transmissibility.

Longchen Xu1,2, Haohang Zhang1,2, Hengyi Xu3, Han Yang4, Lei Zhang4, Wei Zhang1,2, Fei Gu4, Xun Lan2,5,6.   

Abstract

Multiple new variants of SARS-CoV-2 have been identified as the COVID-19 pandemic spreads across the globe. However, most epidemic models view the virus as static and unchanging and thus fail to address the consequences of the potential evolution of the virus. Here, we built a competitive susceptible-infected-removed (coSIR) model to simulate the competition between virus strains of differing severities or transmissibility under various virus control policies. The coSIR model predicts that although the virus is extremely unlikely to evolve into a "super virus" that causes an increased fatality rate, virus variants with less severe symptoms can lead to potential new outbreaks and can cost more lives over time. The present model also demonstrates that the protocols restricting the transmission of the virus, such as wearing masks and social distancing, are the most effective strategy in reducing total mortality. A combination of adequate testing and strict quarantine is a powerful alternative to policies such as mandatory stay-at-home orders, which may have an enormous negative impact on the economy. In addition, building Mobile Cabin Hospitals can be effective and efficient in reducing the mortality rate of highly infectious virus strains. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11071-021-06705-8.
© The Author(s) 2021.

Entities:  

Keywords:  COVID-19; COVID-19 control strategy; Competitive evolution; SARS-CoV-2 evolution; SIR model

Year:  2021        PMID: 34334951      PMCID: PMC8300993          DOI: 10.1007/s11071-021-06705-8

Source DB:  PubMed          Journal:  Nonlinear Dyn        ISSN: 0924-090X            Impact factor:   5.022


  30 in total

1.  Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease 2019 Treated in a Mobile Cabin Hospital.

Authors:  Wei Wang; Can Xin; Zhongwei Xiong; Xixi Yan; Yuankun Cai; Keyao Zhou; Chuanshun Xie; Tingbao Zhang; Xiaohui Wu; Kui Liu; Zhiqiang Li; Jincao Chen
Journal:  Chest       Date:  2020-05-08       Impact factor: 9.410

Review 2.  Origin and evolution of pathogenic coronaviruses.

Authors:  Jie Cui; Fang Li; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

Review 3.  Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus.

Authors:  Marion Sevajol; Lorenzo Subissi; Etienne Decroly; Bruno Canard; Isabelle Imbert
Journal:  Virus Res       Date:  2014-10-17       Impact factor: 3.303

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  Superspreading and the effect of individual variation on disease emergence.

Authors:  J O Lloyd-Smith; S J Schreiber; P E Kopp; W M Getz
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

6.  Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.

Authors:  Kathy Leung; Marcus Hh Shum; Gabriel M Leung; Tommy Ty Lam; Joseph T Wu
Journal:  Euro Surveill       Date:  2021-01

7.  Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.

Authors:  Nathan D Grubaugh; William P Hanage; Angela L Rasmussen
Journal:  Cell       Date:  2020-07-03       Impact factor: 41.582

8.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

9.  Clinical characteristics of moderate COVID-19 patients aggravation in Wuhan Stadium Cabin Hospital: A 571 cases of retrospective cohort study.

Authors:  Lei Shu; Xiaoyan Wang; Mingquan Li; Xiaolin Chen; Ningfei Ji; Lei Shi; Mingjing Wu; Kaili Deng; Jing Wei; Xueli Wang; Yang Cao; Jiaxin Yan; Ganzhu Feng
Journal:  J Med Virol       Date:  2020-08-16       Impact factor: 2.327

10.  Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.

Authors:  Jing Lu; Jinju Peng; Qianling Xiong; Zhe Liu; Huifang Lin; Xiaohua Tan; Min Kang; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chumin Liang; Lina Yi; Louis du Plessis; Tie Song; Wenjun Ma; Jiufeng Sun; Oliver G Pybus; Changwen Ke
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

View more
  1 in total

1.  Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India).

Authors:  Nitin Khandelwal; Yogesh Chander; Ram Kumar; Himanshu Nagori; Assim Verma; Priyasi Mittal; Riyesh T; Sameer Kamboj; Sukhbir Singh Verma; Subhash Khatreja; Yash Pal; Baldev R Gulati; Bhupendra N Tripathi; Sanjay Barua; Naveen Kumar
Journal:  Front Cell Infect Microbiol       Date:  2021-11-23       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.